Understanding Parkinson’s α-Synuclein Oligomers through Temperature Controls, Small Molecule Inhibitors, and Gaucher Disease Fibroblasts

鄧薇妮

18.207.108.182，Hello！

Close
Search Quick Search Advanced Search Publication Search	Personal Service Member Login Searching History Use Bonus Card SYMSKAN
Browse Browse by University of Graduate Thesis Browse by Pinyin of Graduate Thesis Browse by Conference Proceedings Topic Browse by Conference Proceedings Publisher Browse by Pinyin of Conference Proceedings Browse by eBook Category Browse by eBook Topic Browse by eBook Publisher
Customer Services Authorize Airiti Recommend a Journal

Search Symbol (Half-width)	Description of Search Symbols
Space	"AND" indicates the intertwining of key terms used in a search
Double Quotation Marks ("") ( " " )	Double quotation marks indicate the beginning and end of a phrase, and the search will only include terms that appear in the same order of those within the quotations. Example: "image process" ： " image process "
?	Indicates a variable letter. Entering two ? will indicate two variable letters, and so on. Example: "Appl?", search results will yield apple, apply… e , appl y … ( (often used to English word searches) )
*	Indicates an unlimited number of variable letters to follow, from 1~n. Example: Enter "appl*", search results will yield apple, apples, apply, applied, application…(often used in English word searches) e , appl es , appl y , appl ied , appl ication … ( (often used to English word searches) )
AND、OR、NOT	Boolean logic combinations of key words is a skill used to expand or refine search parameters. (1) AND (1) AND: Refines search parameters (2) OR (2) OR: Expands search parameters (3) NOT: Excludes irrelevant parameters

DOI stands for Digital Object Identifier （ D igital O bject I dentifier ） ,
and is the unique identifier for objects on the internet. It can be used to create persistent link and to cite articles.

Using DOI as a persistent link

To create a persistent link, add「http://dx.doi.org/」「 http://dx.doi.org/ 」 before a DOI.
For instance, if the DOI of an article is 10.5297/ser.1201.002 , you can link persistently to the article by entering the following link in your browser: http://dx.doi.org/ 10.5297/ser.1201.002 。
The DOI link will always direct you to the most updated article page no matter how the publisher changes the document's position, avoiding errors when engaging in important research.

Cite a document with DOI

When citing references, you should also cite the DOI if the article has one. If your citation guideline does not include DOIs, you may cite the DOI link.

DOIs allow accurate citations, improve academic contents connections, and allow users to gain better experience across different platforms. Currently, there are more than 70 million DOIs registered for academic contents. If you want to understand more about DOI, please visit airiti DOI Registration （ doi.airiti.com ）。

Data Source

Basic & Applied Sciences > Chemistry
College of Science > Department of Chemistry

Bibliography Management Tool

Related Links

Report an Issue

Search in Library

There is no full-text available at the moment. Airiti would like to request author's authorization. I would like to provide authorization.

Understanding Parkinson’s α-Synuclein Oligomers through Temperature Controls, Small Molecule Inhibitors, and Gaucher Disease Fibroblasts

藉由溫度控制、小分子抑制劑、及 Gaucher 疾病纖維母細胞來探討帕金森氏症中之 α-Synuclein 寡聚體

鄧薇妮 , Ph.D　　Advisor：陳韻如;洪嘉呈　　

英文

溫度；小分子抑制劑；纖維母細胞；帕金森氏症； α-synuclein ； Parkinson ； Gaucher ； small molecule ； temperature

Abstract │ Reference (145) │ Altmetrics

Abstract 〈TOP〉

Amyloid fibrils of presynaptic α-synuclein are the main constituent of Lewy bodies deposited in substantial nigra of the brain of patients with Parkinson’s disease (PD), the second most prevalent neurodegenerative disorder. Accumulating evidences have indicated that, in vitro, monomeric α-synuclein is an intrinsically disordered protein lacking compact secondary and tertiary structures, and suggested that it adopts a nucleation-dependent pathway to form fibrils. More recently, clinical studies established direct pathological links between Gaucher disease (GD), most common form of lysosomal storage disorder (LSD), to PD, and were further supported by in vitro and in vivo evidence. In spite of mounting knowledge about the role of α-synuclein in PD, several questions remain unanswered. In attempting to more comprehensively understand the structure-function relationship of α-synuclein, we would like to address, firstly, whether and how early stage conformation of α-synuclein affect subsequent oligomerization and fibrillization by thermal treatment; secondly, how the small molecule compounds inhibit α-synuclein fibrillization; and finally, whether GD fibroblasts demonstrate mitochondria defects and the subsequent effects on α-synuclein oligomerization.
In part 1 of my dissertation, I examined the α-synuclein conformational changes and the subsequent effects by temperature pretreatment. Our result demonstrated that after 1 hr of high temperature pretreatment, >80 °C, -synuclein fibrillization was significantly inhibited. However, the temperature melting coupled with circular dichroism spectra showed that -synuclein conformation was fully reversible and the NMR studies showed no observable structural changes of α-synuclein after 95 °C treatment. By using cross-linking and analytical ultracentrifugation, rare amount of pre-existing -synuclein oligomers were found to decrease after the high temperature treatment. In addition, a small portion of C-terminal truncation of -synuclein also occurred. The reduction of pre-existing oligomers of α-synuclein may contribute to less seeding effect that retards the kinetics of amyloid fibrillization. Overall, our results showed that the pre-existing oligomeric species is a key factor contributing to -synuclein fibrillization. Our results facilitate the understanding of -synuclein fibrillization. 
In part 2 of my dissertation, I investigated the mechanism of small molecules to inhibit α-synuclein fibrillization. I screened a total of 17 small molecules to inhibit for α-synuclein fibrillization with ThT fluorescence detection. All compounds showed inhibition effects, whereas WCCMK-29 exhibits the most potent to reduce α-synuclein fibrillization, followed by WCCKT-49. Fewer fibrils were found after compounds treatment under electron microscopy. Interestingly, size exclusion chromatography and 4,4’Bis(1-anilinonaphthalene-8-sulfonate) fluorescence binding data indicate that WCCMK-29 has the tendency to interact with α-synuclein oligomer rather than to monomer forms. Moreover, WCCKT-49 reduced the toxicity effects of α-synuclein in BE(2)-C human neuroblastoma cells and potentially protect C. elegans in vivo model of PD. These findings suggest that WCCKT-49 may be potential candidate as therapeutic agent for the treatment of PD and synucleinopathies. 
In part 3 of my dissertation, I investigated mitochondria defects in fibroblasts obtained from GD patients harboring N370S and L444P mutations in β-glucocerebrosidase (GCase). Our results showed that both mutant GCase fibroblasts demonstrated mitochondria fragmentation, increased total reactive oxygen species, superoxide level, and decreased membrane potential. To alleviate the mitochondria dysfunction in N370S, we treated NN-DNJ to the fibroblasts that have been previously known to increase GCase activity of N370S fibroblasts. The results demonstrated that NN-DNJ alleviate mitochondria fragmentation of N370S fibroblasts. However, it showed minor effects on reducing superoxide level and increasing membrane potential. Furthermore, overexpressing α-synuclein in fibroblasts induced α-synuclein aggregates-like formation and increased mitochondria fragmentation. Interestingly, N370S fibroblasts demonstrated higher aggregates formation than L444P fibroblasts. Further characterization of α-synuclein aggregates-like formation is needed to better understand its contribution to mitochondria cellular defects.

Reference ( 145 ) 〈TOP〉

8 REFERENCES
連結：
1. Masuda, M., et al., Small molecule inhibitors of alpha-synuclein filament assembly. Biochemistry, 2006. 45(19): p. 6085-94.
連結：
2. Goker-Alpan, O., et al., Parkinsonism among Gaucher disease carriers. Journal of Medical Genetics, 2004. 41(12): p. 937-940.
連結：
3. Aharon-Peretz, J., H. Rosenbaum, and R. Gershoni-Baruch, Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N Engl J Med, 2004. 351(19): p. 1972-7.
連結：
4. Mazzulli, Joseph R., et al., Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies. Cell. 146(1): p. 37-52.
連結：

Altmetrics

〈TOP〉

E-mail ：

When an article is available to download, a notice will be sent to your mailbox address.

E-mail ：